NCT03320993

Brief Summary

Postprandial glucose control is a challenging issue in everyday diabetes care. Indeed, excessive postprandial glucose excursions are the major contributors to plasma glucose (PG) variability in subjects with type 1 diabetes (T1DM). In addition, the poor reproducibility of postprandial glucose response is burdensome for patients and healthcare professionals. To date, the majority of prandial insulin dosing algorithms for subjects with T1DM considers only the carbohydrate (CHO) content of the meal. However, there is evidence (although with a certain degree of heterogeneity) that meal composition significantly affects postprandial glucose control, contributing to glycemic variability. Moreover, despite the high prevalence of alcohol consumption among patients with T1DM (about 30%, similar to that of the general population), data regarding its effect on the postprandial period are very limited. This project will evaluate the effect of meal composition and alcohol consumption on postprandial glucose control in subjects with T1DM under intensive insulin treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 20, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 25, 2017

Completed
1 year until next milestone

Study Start

First participant enrolled

October 25, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2020

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2020

Completed
Last Updated

March 9, 2020

Status Verified

March 1, 2020

Enrollment Period

1.2 years

First QC Date

October 20, 2017

Last Update Submit

March 6, 2020

Conditions

Keywords

post-prandial glucose controlalcohol

Outcome Measures

Primary Outcomes (1)

  • Plasma Glucose

    Post-prandial plasma glucose time series

    6 hours (plasma glucose will be measured every 5-15 minutes during the 6-hour post-prandial period of each mixed meal test).

Secondary Outcomes (1)

  • AUC-PG

    AUC of plasma glucose will be calculated for the whole 6 hour post-prandial period, for the early 0-3 hour post-prandial period and for the late 3-6 hour post-prandial period.

Other Outcomes (4)

  • Time in range

    6 hours (time in range during the 6 hour post-prandial period)

  • C Max

    6 hours (maximum plasma glucose concentration during the 6 hour post-prandial period)

  • T max

    6 hours (Time of maximum plasma glucose concentration during the 6 hour post-prandial period)

  • +1 more other outcomes

Study Arms (3)

Low Protein-Low Fat study

ACTIVE COMPARATOR

Subjects will receive a mixed meal with carbohydrates (70g) plus a low content of proteins and fats

Other: Mixed meal with different macronutrient composition

High Protein-High Fat study

EXPERIMENTAL

Subjects will receive a mixed meal with the same carbohydrates content of arm 1 (70g), but a greater amount of fats and proteins

Other: Mixed meal with different macronutrient composition

High Protein-High Fat & alcohol study

EXPERIMENTAL

Subjects will receive the same mixed meal of the High Protein-High Fat study plus 0,7g of alcohol per Kg of weight

Other: Mixed meal with different macronutrient composition

Interventions

A mixed meal with identical amount of carbohydrates but different content of protein, fat and alcohol will be given

High Protein-High Fat & alcohol studyHigh Protein-High Fat studyLow Protein-Low Fat study

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with type 1 diabetes mellitus for more than one year, aged between 18 and 60 years; on intensive insulin therapy by means of CSII (continuous subcutaneous insulin infusion) or MDI (multiple daily injections) for at least 6 months before screening; glycosylated haemoglobin of 6-8.5%; without severe chronic micro- and macroangiopathic diabetic complications and with a body mass index (BMI) between 18 and 30 kg/m2.

You may not qualify if:

  • Pregnancy and lactation
  • Hypoglycemia unawareness
  • Fatal or progressive disease
  • Drugs or alcohol abuse
  • HIV, active hepatitis B, active hepatitis C
  • Hepatic disease (aminotransferases AST or ALT \>2 times above normal)
  • Clinically relevant microangiopathic disease, or other diseases that may interfere with participation in the study or data analysis
  • Pre-planned surgery
  • Blood donation in the previous 3 months for men and 6 months for women
  • Mental conditions that may interfere with the subject's comprehension of the aims and possible consequences of the study
  • Non-compliant subjects
  • Use of experimental medications or devices during the previous 30 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Francesc de Borja

Gandia, Valencia, 46072, Spain

Location

Related Publications (6)

  • Bell KJ, Smart CE, Steil GM, Brand-Miller JC, King B, Wolpert HA. Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era. Diabetes Care. 2015 Jun;38(6):1008-15. doi: 10.2337/dc15-0100.

    PMID: 25998293BACKGROUND
  • Bell KJ, Toschi E, Steil GM, Wolpert HA. Optimized Mealtime Insulin Dosing for Fat and Protein in Type 1 Diabetes: Application of a Model-Based Approach to Derive Insulin Doses for Open-Loop Diabetes Management. Diabetes Care. 2016 Sep;39(9):1631-4. doi: 10.2337/dc15-2855. Epub 2016 Jul 7.

    PMID: 27388474BACKGROUND
  • Barnard K, Sinclair JM, Lawton J, Young AJ, Holt RI. Alcohol-associated risks for young adults with Type 1 diabetes: a narrative review. Diabet Med. 2012 Apr;29(4):434-40. doi: 10.1111/j.1464-5491.2012.03579.x.

    PMID: 22248115BACKGROUND
  • Turner BC, Jenkins E, Kerr D, Sherwin RS, Cavan DA. The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diabetes Care. 2001 Nov;24(11):1888-93. doi: 10.2337/diacare.24.11.1888.

    PMID: 11679452BACKGROUND
  • Kerr D, Cheyne E, Thomas P, Sherwin R. Influence of acute alcohol ingestion on the hormonal responses to modest hypoglycaemia in patients with Type 1 diabetes. Diabet Med. 2007 Mar;24(3):312-6. doi: 10.1111/j.1464-5491.2006.02054.x.

    PMID: 17263767BACKGROUND
  • Garcia A, Moscardo V, Ramos-Prol A, Diaz J, Boronat M, Bondia J, Rossetti P. Effect of meal composition and alcohol consumption on postprandial glucose concentration in subjects with type 1 diabetes: a randomized crossover trial. BMJ Open Diabetes Res Care. 2021 Oct;9(1):e002399. doi: 10.1136/bmjdrc-2021-002399.

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Paolo Rossetti, PhD

    Hospital Francesc de Borja, Gandia

    PRINCIPAL INVESTIGATOR
  • Jorge Bondia Company, PhD

    Universitat Politècnica de València

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Data analysis will be carried out by a person not involved in the study (she/he will be blind to the study condition)
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: 3-period, 3-treatment crossover design
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 20, 2017

First Posted

October 25, 2017

Study Start

October 25, 2018

Primary Completion

January 23, 2020

Study Completion

January 31, 2020

Last Updated

March 9, 2020

Record last verified: 2020-03

Locations